Cook Research Incorporated history

In 1964, Dotter first described what is known as angioplasty.

Dotter would be nominated in 1978 for the Nobel Prize for pioneering interventional radiology, a specialty that uses minimally invasive procedures to gather images of practically every organ system in the body.

Cook told an interviewer in 1980 he never expected to make much more than $1,000 a month selling his products when he started.

In November 1982, Bill Cook and Neal Fearnot first discussed the possibility of starting a company to serve as a research and development arm of the Cook Medical companies.

Incorporation papers were signed to form MED Institute, Incorporated (MED) on May 26, 1983, with Neal Fearnot as president.

Carl joined Cook Group in 1988, the company founded by his father, Bill Cook.

Cook Biotech’s first two employees, Michael Hiles and Umesh Patel, in 1995, with the first piece of SIS produced at Cook Biotech

In 2002, Cook MyoSite, Incorporated was formed to guide the Cook Group organization into the expanding world of cellular technologies.

In 2011, the FDA issued a safety communication stating that serious complications from the use of TVM were not rare and reclassified the mesh as a “high-risk” medical device.

First approved by the United States Food and Drug Administration (FDA) in 2012, Cook’s Zenith aortic stent grafts have revolutionized procedures to repair the aorta.

July 2014 696 CloverSnare 4-Loop Vascular Retrieval Snare devices used to retrieve or manipulate foreign objects such as balloons, catheters or filters in blood vessels.

To further the mission of Cook Medical providing medical products to patients, MED Institute was divided into two separate companies in 2015.

As of May 2017, more than 1,900 lawsuits were still pending against Cook over its IVC filters in a MDL before an Indiana federal court.